Please ensure Javascript is enabled for purposes of website accessibility

Tag Archives: Alexsandar Nikolic

IP Frontiers: What’s on sale? The latest on the patent novelty requirement

Alexsandar Nikolic

On Jan. 22, 2019, the Supreme Court provided its decision in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc.[1] Despite receiving little publicity outside the patent world, it nonetheless has implications for small businesses. The decision provided clarification to the ...

Read More »